Oxibendazole

This classification denotes an antihelminthic agent with the molecular formula C12H15N3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 022N12KJ0X, chemically known as 2-benzimidazolecarbamic acid, 5-propoxy-, methyl ester but generally known as oxibendazole, which bears US NIH Compound Identifier 4622. European Medicines Agency schedules Oxibendazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09521MIG. The term OXIBENDAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 28, No. 10 1974, List 14). OXIBENDAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule oxibendazole under HS 29339990 and SITC 51577. As of Q4 2014, OXIBENDAZOLE remains the US FDA Preferred Term for this commodity. Oxibendazole bears US NLM identifiers UMLS ID C0069763 and NCI Concept Code C66262. SMILES: CCCOC1=CC2=C(C=C1)N=C(N2)NC(=O)OC.